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Abstract
Background: In Sri Lanka filariasis is endemic in Southern, Western and North Western provinces covering
eight districts designated as implementation units in the Programme for the Elimination of Lymphatic Filariasis
(PELF). Despite control activities over sixty years including multidose diethylcarbamazine, 6 mg/kg treatment
microfilaria rates had persisted at low levels. Following systematic social mobilisation the first MDA with DEC
albendazole combination was conducted in 2002.
Methods: We investigated the extent social mobilisation had reached the people, their drug compliance and
adverse reactions. Three localities were selected from each district to pick target population samples for pre-
tested questionnaire. Three teams each with six people visited one district each day. One team worked from
three starting points in one locality. A member applied eight part questionnaire to one family member totalling
150–160 people from one locality. Questions included social mobilisation, drug compliance and adverse reactions.
Results: Information was disseminated by television, radio, banners and leaflets, to a lesser extent by people.
Information reached more people in the periphery than in Colombo. 35.2% from Colombo municipality were
unaware of the MDA. Drug coverage was 79.6%, home delivery 71.7% and delivery centres 7.9%. 35.6% in
Colombo district and 53.4% from Colombo municipality did not receive drugs. Drugs were consumed by 71.4%.
28.6% who did not comply included 20.4% who did not receive them. 91.4% showed no adverse reactions, 7.5%
were mild, 1.1% recovered with home remedies.
Conclusion: Drug compliance showed significant positive correlation with awareness of the MDA. Door to door
delivery was more successful than delivery from centres. More delivery centres conveniently located would have
rectified this disparity. Poor awareness and compliance in Colombo and urban areas could be rectified with
separate strategy for urban areas. More time for MDA and trained adequate manpower would ensure coverage
to achieve elimination.
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Background
Lymphatic filariasis is one of the major vector borne dis-
eases in Sri Lanka, a disabling and disfiguring infection
causing social stigma and economic reductions in life
opportunities. The infection prevalent in Sri Lanka is
Wuchereria bancrofti. The national control programme has
recognised three provinces, Southern, Western and North
Western as the areas where the disease is endemic on the
island [1] (Fig. 1). The area is about 500 sq miles in extent
and has a population of 9.8 million at risk. The land is rel-
atively flat sloping towards the sea and is traversed by sev-
eral streams and rivers. Much of the area is in the wet zone
receiving a rainfall from the southwest monsoon.
In Sri Lanka despite control activities over a period of fifty
years microfilaremia rates persisted at a low level. Selec-
tive treatment with multi-dose regimens of diethylcar-
bamazine (DEC), 6 mg/kg daily for consecutive days [2]
on microfilaria (mf) carriers was the policy in operation at
the time. The introduction in the late 1990's of mass treat-
ment with single dose DEC and subsequently in combina-
tion with albendazole has become a landmark in the
treatment and control of lymphatic filariasis. The single
dose combination of DEC (6 mg/kg) and albendazole
(400 mg) is now accepted as the treatment of choice for
mass drug administration (MDA) in countries outside
Africa where onchocerciasis is co-endemic with lymphatic
filariasis [3]. Recent advances in methods both for con-
trolling transmission and for simple and successful
approaches for morbidity control [4] along with improve-
ment in techniques for diagnosing infection [5] resulted
in the World Health Assembly in 1997 to call on the WHO
to initiate programmes to eliminate lymphatic filariasis as
a public health problem in endemic countries [6]. Sup-
porting this action SmithKline Beecham (now Glaxo-
SmithKline), commencing 1998, committed to donate via
WHO albendazole to ensure the success of the elimina-
tion programme until 2020 [6]. Given this background
the health ministries of countries with lymphatic filariasis
established national elimination programmes [7].
Programme for the Elimination of Lymphatic Filariasis
Sri Lanka set up a national Programme for the Elimina-
tion of Lymphatic Filariasis (PELF) in 1999 [8] based on
the protocols recommended by the WHO [9]. The Minis-
try of Health identified the eight districts in three prov-
inces where the disease is endemic as the smallest
implementation units (IUs), which would be responsible
for the administration of the PELF. An information, edu-
cation and communication (IEC) campaign was set up
before the MDA programme. The Ministry with the assist-
ance of the World Health Organisation in 2002 prepared
an intense and systematic social mobilisation programme
called Communication-for-Behavioural Impact (COMBI)
to support MDA efforts in Sri Lanka [10]. This programme
used: (a) print media which utilised newspapers for arti-
cles and announcements, leaflets distributed to people
and posters, banners and sign boards displayed in public
places (b) electronic media where periodic television and
radio programmes and short messages were transmitted.
The topics included the disease and its symptoms, trans-
mission of the parasite by the mosquito, treatment includ-
ing single dose mass treatment with the combination of
DEC and albendazole to be given annually for five years
on the national 'filariasis day', the day assigned by the
government for drug delivery and the additional benefits
of albendazole, adverse reactions and prevention, mor-
bidity management and control.
A vigorous and extensive training programme was carried
out by the trainers to educate staff engaged in the Pro-
gramme on all aspects of the disease, treatment with sin-
gle dose MDA, how to conduct drug distribution and how
to advise the target population on adverse effects and its
contraindications. Each category and level of staff received
training.
The PELF is under the responsibility of the Director of the
National Filariasis Campaign who is the Programme Man-
ager under whom medical officers and public health per-
sonnel carry out the programme. Under a decentralised
system the programme is conducted in each IU in the
three provinces through the Provincial Directors of Health
(PDHs), and other public health staff under each Provin-
cial Director of Health. The health personnel involved are
mainly the public health nurses, public health inspectors
and family health workers (FHW) formerly known as
midwives who attend to the health and midwifery matters
of the community.
The Programme Manager and the heads of the IUs
obtained the required number of doses of the drugs, DEC,
in the form of 50 or 100 mg tablets and albendazole in
400 mg tablets based on the census population, from the
Ministry's central drug stores and allocated them to deliv-
ery staff through the MOHs a few days prior to the date of
the MDA. The dosage of DEC was 300 mg for adults and
150 mg for children approximately to 6 mg per kg body
weight. Drug delivery was conducted by two methods,
door to door by deliverers visiting households and
through delivery points and health centres from where
people collected their drugs. In order to assist in drug
delivery the MOHs in the IUs recruited volunteers among
young people in the villages. Door to door delivery was
conducted by volunteers, FHW and other health person-
nel. Each deliverer had to cover about 50 households.
The Programme is being monitored at different levels of
implementation. These include availability of supplies at
every level, availability of staff in adequate numbers andFilaria Journal 2007, 6:11 http://www.filariajournal.com/content/6/1/11
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District map of Sri Lanka with the endemic area (districts) shaded Figure 1
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their training, completed efficiency reports to the higher
administration levels, regular assessment of drug require-
ments and active surveillance for adverse reactions.
The first MDA in the national PELF covering the entire
endemic region in 1999 using DEC, reported by the pro-
gramme management [1], delivered the drug to only
62.7% of the population. In 2000 two rounds of MDA,
again using only DEC, reported coverage of 68.2% in
April and 70.5% in November. In the May 2001, when a
limited supply of albendazole was available, the combi-
nation of DEC and albendazole was administered as a
trial only in the Colombo district and achieved coverage
of 76.7%. DEC alone was administered in the other seven
districts. Following the implementation of the COMBI
programme the first countrywide MDA using the two-
drug combination was carried out in July 2002 with a
reported coverage of 80% of the population. An inde-
pendent evaluation of this programme was conducted in
two localities in the Galle district [11].
The second round of the MDA with the two-drug combi-
nation was carried out on 27 July 2003 with a continuing
social mobilisation campaign. An independent evalua-
tion of this MDA programme by the Filariasis Research
Training and Service Unit, Faculty of Medicine, University
of Ruhuna, Galle to cover all IUs of the endemic region
was carried out during 12 – 23 August 2003 after the final
"mopping up" drug delivery. The observations of the IEC
and drug compliance are presented in this report.
Methods
Study areas
The eight districts included in the MDA programme were
Hambantota, Matara and Galle in the Southern Province,
Kalutara, Colombo and Gampaha in the Western Prov-
ince, Kurunegala and Puttalam in the North Western
Province (Fig. 1). The population of the area covering
these districts is 9.8 million according to the Census of
Population and Housing-2001. Three localities were
selected from each district – mainly urban and suburban
areas placed some distance from one another. In addition
localities in three wards in the Colombo Municipality on
the basis of housing and living standards of the popula-
tion were selected. These localities are shown in Fig. 2.
Method of house selection
Three teams participated in the survey. Each team con-
sisted of six persons; five trained assistants and a doctor.
The three teams worked in one IU on a single day, each
team covering a single locality. In a locality the team
selected three starting points along roads and streets
placed some distance away from one another and two
assistants commenced work from one starting point. They
visited households on either side of the selected road. The
houses which were closed were not surveyed. The ques-
tionnaire was applied directly to one adult from a family.
Where two families lived in the same household one from
each family was interviewed. Each assistant interviewed
Ward map of Colombo Municipality area showing the locali- ties investigated Figure 2
Ward map of Colombo Municipality area showing the locali-
ties investigated.Filaria Journal 2007, 6:11 http://www.filariajournal.com/content/6/1/11
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about 30 people, covering about 50 to 60 households
along each road with an aim of a team covering about 150
to 160 people in the locality.
Questionnaire
The pre-tested questionnaire had eight questions. The first
was to ascertain how far the social mobilisation pro-
gramme had reached the people and what the most suc-
cessful method was in each locality. The second was on
drug delivery, whether the drugs were delivered to the
homes and by whom or whether they were collected at
delivery centres. The third was to ascertain whether the
drugs were delivered to them, on the national "Filariasis
Day", in this instance Sunday 27 July, or later. The ques-
tion of drug compliance was most important. The fourth
and the fifth questions were whether the drugs were swal-
lowed and the time the people swallowed them. In the
sixth question we sought the reasons for not consuming
the drugs from those who failed to do so. The seventh con-
cerned the adverse effects following drug consumption,
their degree of discomfort and whether they affected their
day-to-day activities. The final question was whether the
people knew about the purpose of the MDA. Ethical clear-
ance for this study was obtained from the Ethics Commit-
tee, Faculty of Medicine, University of Ruhuna, Galle, Sri
Lanka.
Analysis
The data from the responses to questions in the question-
naire in each district (IU) were validated and analysed
using SPSS 7.2 computer software (SPSS Inc., Chicago, IL,
USA). Any association in the response to MDA between
localities and districts was examined using the Chi square
test.
Results
A total of 4,358 people from 2,830 households were inter-
viewed from 27 localities in the 8 districts and from three
wards in the Colombo Municipality averaging about 160
people in about100 households from each locality.
Details of population samples, their percentage of the Dis-
trict population and the number of households visited are
given in Table 1.
The responses to each of the eight questions from all the
localities were added together under each district. The
people interviewed were of the age range 20 to 75 years.
Females interviewed exceeded males in most localities in
the ratio of around 3:2 mainly because interviews were
conducted during working hours when men were away
from home.
Social mobilisation
The social mobilisation programme by means of the IEC
campaign about the MDA had been transmitted to the
population by four media sources, television, radio, ban-
ners and leaflets (Fig. 3). The media message to the people
interviewed had reached from 40.1% in Hambantota and
Puttalam districts to 52.0% in the Colombo district.
While the television and radio conveyed the message to
most people in all districts, banners and leaflets were the
most widely viewed message in Colombo district. Loud-
speakers had also been popular in Kurunegala and Matara
districts.
The FHW who form a regular cadre in the national Depart-
ment of Health and volunteers had participated widely in
the programme. Their participation ranged from 18.2% in
the Colombo district to 32.2% in Kurunegala and Ham-
bantota and 38.4% in Puttalam.
Table 1: The population samples interviewed in eight districts (IUs) with a comparison of the observed and reported drug coverage in 
the independent evaluation of the July 2003 national MDA.
Population sample interviewed
Province District (IU) District Population 
(Millions)†
No of people % District 
Population
% Observed 
drug coverage
% Reported drug 
coverage*
P value
Southern Hambantota 0.53 490 0.09 96.3 93.0 0.30
Matara 0.76 478 0.06 81.8 87.0 0.31
Galle 0.99 470 0.05 80.2 83.0 0.61
Western Kalutara 1.06 497 0.05 91.8 89.0 0.50
Colombo 1.86 475 0.03 64.4 88.7 P < 0.001
Gampaha 2.07 510 0.02 70.6 84.5 0.02
North Western Kurunegala 1.45 477 0.03 89.5 82.0 0.13
Puttalam 0.71 478 0.07 94.8 85.0 0.02
Colombo Municipality 0.38 483 0.13 46.6 88.7 P < 0.001
Total 9.80 4358 0.04 79.6 86.8 0.17
† Census of Population and Housing-2001, Department of Census and Statistics, Government of Sri Lanka, 2003.
* Source: Courtesy Programme Manager, National PELF.Filaria Journal 2007, 6:11 http://www.filariajournal.com/content/6/1/11
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In the wards of the Colombo Municipality which were
surveyed, 32.5% were not aware of the MDA programme.
19.2% in Galle district and 18.0% in Gampaha district
were also unaware of the MDA programme. This is in con-
trast to the 15.6% in Colombo district (P < 0.001); 12.1%
in Puttalam and Kalutara districts (P < 0.001); 10.1% in
Kurunegala district (P < 0.001) and 9.2% in Hambantota
district (P < 0.001). In the total sample from the endemic
region 43.1% had the information through the media,
27.6% from the health workers and volunteers and 13.1%
from the media and personnel. Whilst overall 16.2% of
the people had not heard about the MDA.
Drug coverage
We compared observed coverage with the reported cover-
age from the national MDA programme of June 2003 (see
Table 1). Our observed coverage for the total area of
79.6% compared favourably with the reported coverage of
86.8%. The observed coverage of all districts except
Colombo district and Colombo city wards sampled were
not statistically significant and therefore consistent with
the reported coverage. The observed coverage of 64.4% in
the Colombo district and 46.6% in the Colombo city
wards were low compared to reported coverage of 88.7%
(P < 0.001) and 88.7% (P < 0.001) respectively.
Delivery achieved the highest coverage in Hambantota,
Puttalam, Kalutara and Kurunegala districts (Fig 4). Door
to door coverage was the more successful method of get-
ting the drugs to the people largely undertaken by volun-
teers. The most effective delivery was by the volunteers in
the districts of Puttalam (86.8%), Hambantota (80.6%)
and Kalutara (72.2%). FHWs undertook drug delivery effi-
ciently in the six districts they participated in, the highest
being 17.4% in Matara. Delivery from centres had been
poor. The only noteworthy figure was from Matara district
where 28.9% of the interviewees collected their drugs
from health centres.
Overall drug coverage had been poor in the districts of
Colombo and Gampaha with 35.6% of the population in
Colombo and 29.4% in Gampaha not receiving drugs. In
the three wards in the Colombo municipality a worrying
53.4% of the people interviewed had not received the
drugs. This was in contrast with the 3.7% who did not
receive drugs in Hambantota (P < 0.0001) and 5.2% in
Puttalam (P < 0.0001) and 8.2% in Kalutara (P < 0.0001).
In the sample interviewed 891 (20.4%) had not received
drugs. Among 3,467 who received drugs 2,404 (55.2%)
had them delivered to their homes by volunteers, 438
(10.1%) by FHWs and a further 281 (6.4%) by other
health care personnel. Only 344 (7.9%) people received
drugs from health centres. In all the 8 districts and in the
Colombo Municipality between 71.1% and 95.3% of the
people received the drugs on the "Filariasis Day".
The extent of Information, Education and Communication (IEC) coverage in individual districts by different methods Figure 3
The extent of Information, Education and Communication (IEC) coverage in individual districts by different methods.
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Drug consumption
Drug consumption had been highly successful in all dis-
tricts. Most people who received the drugs had swallowed
them. This group ranged from 83.3% in Colombo district
and 94.6% in Kurunegala district. The wards taken up in
the Colombo Municipality had a consumption rate of
89.1%.
In Galle, Matara, Kalutara, Gampaha and Colombo Dis-
tricts over 95.0% of the people who swallowed the drugs
had done so at night after meals. This proportion was over
82.0% in the other districts.
In all the districts 3,111 (71.4%) of the interviewees had
consumed the drugs and 356 (8.2%) had not consumed
them. 131 (3.1%) had refused drugs because they were
under some other medication, 139 (3.2%) felt they did
not need them, 48 (1.1%) had forgotten to consume them
and only 38 (0.8%) were worried about adverse effects.
Drug consumption vs. awareness of the MDA
There was a significant positive correlation between drug
consumption and awareness of the MDA in all 27 locali-
ties visited (P < 0.0001) as shown by Fig. 5. Among the
3,111 who consumed the drugs 2,504 were aware of the
MDA and 607 were ignorant of it. 219 of the 356 who did
not comply were aware of the reasons for the MDA and
137 were not aware. Considering those who were aware of
the MDA 91.9% of them had a valid reason for compli-
ance (P < 0.0001) and 8.1% did not comply.
Adverse reactions
The majority of the people interviewed in all districts and
in Colombo Municipality had not reported any adverse
effects. Of the total of 3,111 who consumed the drugs,
2,844 (91.4%) suffered no adverse reactions. Of the 269
(8.6%) who reported adverse reactions 79 (2.5%) com-
plained of headaches and 34 (1.1%) complained of weak-
Relationship between awareness of IEC and Compliance Figure 5
Relationship between awareness of IEC and Compliance.
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Observed drug coverage by different methods in individual districts Figure 4
Observed drug coverage by different methods in individual districts.
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ness. Other adverse reactions reported were dizziness 25
(0.8%), drowsiness 21 (0.7%), faintness 18 (0.6%), nau-
sea 17 (0.5%), vomiting 15 (0.5%), fatigue 16 (0.5%),
abdominal pain 12 (0.4%), headache and diarrhoea 13
(0.4%), headache and nausea 9 (0.3%), diarrhoea 6
(0.2%), fever 2 (0.1%) and rash 2 (0.1%). Severity was
divided into three categories, mild (no interference with
daily activity), moderate (interference with daily activity
and recovery after home medication) and severe (seeking
hospital admission). Among the 269 (8.6%) people with
adverse reactions 236 (7.5%) were mild and 33 (1.1 %)
were moderate. There were no severe cases, which needed
hospital admission.
Purpose of the MDA
A mean of 33.04% of people interviewed knew that the
purpose of the MDA was elimination of the disease. They
ranged from 22.0% in Galle district to 38.8% in Kalutara
district. Gampaha district (38.4%), Hambantota (35.5%)
and Puttalam (32.4%) recorded a high awareness about
elimination. A higher proportion of the interviewees,
32.1% – 48.7% (mean 40.48%) thought the reason was
prevention, the highest being in Puttalam district with
48.7%. Colombo, Matara, Kurunegala and Hambantata
districts recorded over 40%. Between 18.8% and 38.5%
did not know the purpose of the MDA. This ignorance was
shown in 38.5% of the three wards in the Colombo
Municipality investigated.
Discussion
The present evaluation of an MDA in the national PELF
was the first of its kind conducted by an independent
group covering all eight districts in the endemic region.
Our aim was to ascertain to what extent the IEC pro-
gramme had reached the target population, the degree of
success achieved in drug delivery and compliance and the
extent of adverse reactions. Another independent survey
[12] dealt with a target population in two Grama Niladari
divisions and two clinics in the Gampaha district.
The IEC programme reached more people in the periph-
eral districts than in Colombo district and in Colombo
municipality. The ignorance of the MDA shown by the
interviewees of the Galle municipality area was reflected
in the low awareness shown in the Galle district. In gen-
eral, low awareness was evident in the urban areas we vis-
ited in all districts.
The combination of television, radio and loudspeakers
was successful in carrying the message to 50.9% of the
people whereas the percentage who had received the mes-
sage verbally was 32.0%. This is in contrast to the situa-
tion in Leogane, Haiti [13]. Of the 91.2% respondents
who knew about the MDA in Leogane, 55.7% heard about
it from other people and 33.0% from radio broadcasts. In
the Zanzibar programme [14] a combined message from
an advisory board from ministries, national institutions,
non-governmental organizations (NGOs), religious
organizations and political parties was disseminated to
the population. In Orissa, India [15] the IEC programme
was run by district medical officers through the network
of municipal health institutions and public health centres
with the financial and technical assistance of the WHO.
Drug delivery strategies for MDA vary by country. In some
programmes e.g. Leogane, Haiti [13] the public had been
requested to collect their drugs from delivery centres.
These centres were located in public places, geographically
well distributed, convenient and easily located. In other
countries delivery had been entirely door to door. In Zan-
zibar [14] trained 'filarial prevention assistants' delivered
the drugs. In Orissa, India [15] trained community volun-
teers and peripheral health workers delivered drugs in the
rural and municipal areas. In Tamil Nadu, India [16]
delivery was implemented through the staff from the Pri-
mary Health Centres in the rural areas and through cate-
gories of health staff in the urban areas. In another
instance in Tamil Nadu [17], they compared drug delivery
by communities, community directed treatment (comDT)
and health services directed treatment.
The national programme in Sri Lanka used two methods
of drug delivery, door to door and from delivery centres.
In our sample 79.6% of the eligible population had
received the drugs. Door to door delivery far exceeded that
achieved by delivery from health centres. Door to door
delivery undertaken by volunteers and health care person-
nel including FHW was the more successful method.
While drug coverage was good in the peripheral districts,
in Colombo district and in the Colombo city our observa-
tions recorded poor coverage compared to reported cover-
age (P < 0.001). Similarly some urban localities in other
districts also showed poor coverage.
In contrast much of the success of the Zanzibar MDA pro-
gramme [14] was attributed to the drug distributors who
were designated filarial prevention assistants (FPAs). They
had been selected on the basis of their experience in pub-
lic health activities and their residence in the community
where the work was to be done. All distributors had T-
shirts with logos for their identification. The training fac-
tor was highlighted in Orissa, India [15] where they found
that in villages with planned training, delivery and com-
pliance was high. Orissa [15] also recorded significantly
lower levels of coverage and compliance in urban areas.
They attributed this to the difference in the nature and
composition of the urban population in addition to their
higher levels of education, occupation and work pattern.
Urban areas clearly need a different strategy to achieve a
higher coverage and compliance to rural areas.Filaria Journal 2007, 6:11 http://www.filariajournal.com/content/6/1/11
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In the sample we interviewed 71.4% of the population
had consumed the drugs. In the 28.6% who had not com-
plied 20.4% had not received the drugs and 8.2% had not
consumed them. The common reasons for non-delivery
of drugs as observed in other programmes [15,16] were
that the drug distributors did not visit the households or
the family was out on the date of delivery. Often coverage
could not be completed due to shortage of personnel and
the time limit for delivery.
The reasons for their failure to consume drugs, apart from
the fear of adverse reactions were the use of other drugs,
not feeling the necessity for them and forgetting. Similar
reasons have been given in other programmes [13,15,16].
All these reasons including some [16] such as, too many
tablets needed to be consumed at one time, poor aware-
ness of the benefits of the drugs and lack of confidence in
the distributors could be eliminated through IEC to
achieve the necessary behaviour change [15].
In some programmes the magnitude of adverse reactions
affected coverage and compliance [14-16,18]. In Leogane,
Haiti [18] 24% (17,421) of those treated during the MDA
reported one or more adverse reactions. Among these
15,916 (91%) had minor adverse reactions which did not
interfere with daily activities. Moderate adverse reactions,
severe enough to interfere with activity were reported by
2% (1,502) of persons treated. In many places in Orissa
[15] as a result of adverse reactions subsequent mopping
up activities were suspended. In Zanzibar [14] the com-
munities were educated to recognise adverse reactions as
evidence of the therapeutic action of the drugs. As a result
the public was willing to accept the drugs. Our observa-
tions in Sri Lanka showed that adverse reactions did not
cause a significant problem. In the sample we assessed
91.4% had no adverse effects at all. Among the 8.6% who
experienced adverse effects 7.5% were mild not needing
attention and 1.1% had recovered after home remedies.
The low adverse effects were probably due to low mf den-
sities among the mf carriers.
We consider that strategies suited to the local situation are
required to improve the MDA coverage and awareness of
the people. Disseminating the message through people as
mentioned above in Haiti and Zanzibar [13,14] could
improve results. For example family health clinics and
outpatient clinics could be utilised where doctors and
health care personnel could address the people. Teachers
could be given instructions on the MDA programme to be
imparted to the children. The children would carry the
message home to the wider population. Politicians in
some districts who had shown commendable interest in
the programme should be requested to help in carrying
message to their constituents. The idea of seeking the
cooperation from religious leaders could be explored
especially in Muslim areas as Muslims will not tradition-
ally welcome strangers in their homes. Wherever possible,
the services of Lions Clubs and other NGOs should be
requested both for IEC work and drug delivery.
The MDA programme needs increased human reservoirs
for drug delivery. A "Filariasis Week" would be preferable
to a "Filariasis Day" as delivery continued beyond one
day. A serious shortcoming was identified with drug dis-
tribution centres as in some localities people had to walk
several kilometres to reach one. There should have been
an increased number of such centres, preferably located in
every street in a given locality to enable people to reach
them easily, as in Leogane, Haiti [13] with regular
announcements giving the location of the centres.
The performance of volunteers varied by district. This was
probably due to the level of training and appearance of
the volunteers in some districts. Members of the public
had no confidence in accepting drugs from some distrib-
utors. They lacked motivation and did not have adequate
incentive as opposed to the drug distributors in Zanzibar
[14]. Choice of personnel therefore becomes important.
Selection of volunteers from medical students, nursing
trainees and even year 12 school children would eliminate
some of these problems. Training also becomes an impor-
tant factor. Intensive training is essential for all drug dis-
tributors on communication skills, on the disease and its
prevention. Therefore, the need for repeated and thor-
ough training of volunteers and other categories of staff at
all levels of the programme [9] cannot be overstressed.
Introduction of mobile clinics equipped with loudspeak-
ers would provide further improvement in drug coverage
and mopping up operations.
Conclusion
The study revealed that the level of awareness of the MDA
and drug coverage in Colombo and urban areas needed to
be raised appreciably to bring them in line with other
areas. This could be rectified by better planning and by
identifying a separate strategy for the urban population.
Drug coverage showed significant positive correlation
with awareness of the MDA. Door to door delivery was
more successful than delivery from health centres. More
delivery centres more conveniently located would have
rectified this disparity. More time for MDA and trained
adequate human resources would ensure coverage to
achieve elimination.
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